During the past decade, Birmingham Childrens Hospital; Oncology Dept conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Birmingham Childrens Hospital; Oncology Dept" are "High Grade Glioma" (1 trials) and "Sarcoma" (1 trials). Many other conditions were trialed in "Birmingham Childrens Hospital; Oncology Dept" in a lesser frequency.

Most popular intervention types in "Birmingham Childrens Hospital; Oncology Dept" are "Drug" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Radiotherapy" (1 trials), "Standard chemotherapy" (1 trials), "Temozolomide (TMZ)" (1 trials) and "bevacizumab [Avastin]" (1 trials). Other intervention names were less common.

The vast majority of trials in "Birmingham Childrens Hospital; Oncology Dept" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Birmingham Childrens Hospital; Oncology Dept". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Birmingham Childrens Hospital; Oncology Dept, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Birmingham Childrens Hospital; Oncology Dept, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".